News | Womens Healthcare | March 31, 2016

American Heart Association Publishes Scientific Statement on Women and Heart Attacks

Statement illustrates the significant shift over time in treatment of acute myocardial infarction in women

American Heart Association, AHA, scientific statement, heart attacks, women, cardiovascular disease

March 31, 2016 — After a lengthy review of increasing medical evidence, the American Heart Association has published a scientific statement on the reduction in cardiovascular disease mortality in women. Per the study, “The dramatic decline in mortality rates for women is attributed partly to an increase in awareness, a greater focus on women and cardiovascular disease risk, and the increased application of evidence-based treatments for established coronary disease.”

“This is absolutely a good news story for women in terms of their health and cardiovascular disease,” said co-author Cindy L. Grines, M.D., vice president of Detroit Medical Center (DMC) Heart Hospital.

While often traditionally considered a disease of men, cardiovascular disease (CVD) is the leading cause of mortality for women in the United States. The study suggests that “although major progress has been made in reducing CVD mortality in women, medical research has historically neglected the health needs of women, apart from reproductive concerns.”

“It’s a longstanding misconception that cancer is the leading killer when it comes to women,” said Grines. “That’s actually second. According to the Centers for Disease Control, heart disease is the No. 1 killer of women in the U.S.”

But since 2000, the incidence of cardiovascular mortality in women has been on a decline, at a degree of thousands of lives saved. What’s changed?

“It’s a combination of advancements in treatment and education about cardiovascular disease among both patients and physicians,” said Grines. “We still have a long way to go in addressing the cardiovascular disease rate for women, but this data is a good indication that we are starting to do the right things, at the right time.”

Education about the differences between men and women in terms of cardiovascular disease and its risk factors has been, and continues to be, a key effort. “For decades, women were seen as ‘smaller men’ as far as heart disease was concerned, and needless to say, that’s incorrect,” said Grines. “There are clear differences in how women experience symptoms, in how the disease affects their body and in the effect risk factors have on their disease.

As an example, Grines cited modifiable risk factors such as depression, obesity and stress, which have very different rates of impact on cardiovascular disease risk – and all of them are higher when it comes to women. Patients and clinicians are learning to recognize symptoms in women that are different, such as shortness of breath, and pain in locations outside the chest, including arms, back, neck, jaw or stomach.

“The data in this new scientific statement is clear and compelling,” said Grines, who is also a professor of medicine at the Wayne State University School of Medicine. “We’ve known for some time that heart disease in women was different, and now we have support for more specific protocols for recognizing and treating it faster and better.”

For more information:

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init